Home » Topics » BioWorld

BioWorld
RSS

AMERICAN BIOGENETIC TO REDEEM WARRANTS

Feb. 4, 1992

AMGEN BEGINS STEM CELL FACTOR TRIALS

Feb. 4, 1992

VIMRX REVISES DOSING SCHEDULE

Feb. 4, 1992

ENZO SHAREHOLDERS TENDER DEBENTURES

Feb. 4, 1992

ATS, MEDISORB MESH TECHNOLOGIES

Feb. 4, 1992

ANALYST RAISES ESTIMATE FOR BIOMIRA

Feb. 4, 1992

CELLCOR FILES FOR 2 MILLION-SHARE IPO

Feb. 4, 1992

MGI RETAINS FAITH IN CHEMOPROTECTIVES

Feb. 4, 1992

ANALYST LOWERS AMGEN RATING

Feb. 3, 1992

GENSIA TO SPLIT STOCK 3 for 2

Feb. 3, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.